tirzepatide in adolescents FDA expands use for mounajro pediatric patients with type ii diabetes DOI 10.1016/S0140-6736(25)01774-X #insulinresistance #diabetes #medical #nursing #glp New Meds and Tech: Mounjaro
Description
Please note* We discount the cost of your first vial of medication by $100
Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis
3.4% in those without gastroparesis
And homeostatic feeding is just, like, you are starving
The drug has a short half-life and needs to be administered by subcutaneous injection three times a day
Are unable to follow a low-fat diet (Orlistat causes unpleasant side effects if too much fat is consumed) 3
